ArticleJournal of immunology (Baltimore, Md. : 1950)2009

A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity.

Yangbing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.